White Adipose Tissue
White adipose tissue is the body's main fat store - an active organ that releases hormones and influences appetite, insulin resistance and inflammation.
Plain English
Patient-Friendly Explanation
Your body holds two broad types of fat tissue. Brown and beige fat burn fuel to make heat. White adipose tissue - by far the larger share in an adult - stores energy. It sits under the skin, where you can pinch it, and deeper inside the body around the organs, where you cannot. What has changed in the science is the understanding that white fat is not a passive larder. It is an active organ that releases hormones such as leptin, which tells the brain how much energy is in store, and inflammatory signals that affect how well insulin works. Where the fat sits matters as much as how much there is: fat under the skin is comparatively harmless, while fat packed around the abdominal organs releases its contents straight into the liver and is much more strongly linked to diabetes, fatty liver and heart disease. When the tissue can no longer expand safely, fat spills into muscle, liver and heart, and that is when metabolic problems begin.
Medical
Clinical Definition
White adipose tissue is the principal energy-storage organ in humans, composed of lipid-laden adipocytes, pre-adipocytes and stromal-vascular cells including tissue macrophages, endothelial cells and fibroblasts. It is an endocrine and immune organ as well as a depot: it secretes leptin, adiponectin, resistin, visceral adipose tissue-derived serpin, retinol-binding protein 4, TNF-alpha, interleukin-6, monocyte chemoattractant protein-1 and free fatty acids. Its two principal compartments differ functionally. Subcutaneous white adipose tissue drains to systemic circulation and is associated with comparatively favourable metabolic profiles, while visceral adipose tissue drains via the portal vein directly to the liver, is more lipolytically active and more densely infiltrated by macrophages, and carries the stronger association with insulin resistance, dyslipidaemia, MASLD and cardiovascular disease. Expansion occurs by hypertrophy of existing adipocytes or recruitment of new ones (hyperplasia); when the storage capacity of the subcutaneous compartment is exceeded, lipid is deposited ectopically in liver, skeletal muscle, myocardium and pancreas - the lipotoxicity model of metabolic disease. Adipose tissue dysfunction, characterised by hypoxia, macrophage crown-like structures and a shift toward pro-inflammatory adipokine secretion, is central to obesity-related insulin resistance. Depot distribution is quantified clinically by waist circumference, DEXA, or MRI and CT fat mapping, while weight loss reduces both depots but disproportionately the visceral one.
Key Insight
Why It Matters
White fat is the tissue your programme is really targeting - and it is an organ, not a passive store, which is why losing it changes blood pressure, blood sugar and liver enzymes as well as your size. We track waist circumference as well as weight because the deep fat around the organs is the part that carries the risk.
Where this fits
White Adipose Tissue is one of the concepts that comes up in GLP-1 treatment at our clinic. If you are reading about it because of your own weight, the next practical step is a clinical assessment, see GLP-1 weight loss treatment for how the programme works, what it involves and what it costs.
Sources
Reviewed against standard medical references.
Medically reviewed by
Family Physician & Registered Acupuncturist, Accord Medical Clinic. MBBS (NUS), Graduate Diploma in Family Medicine (NUS), Graduate Diploma in Acupuncture (Singapore College of TCM).
Last reviewed: September 2026
This page is general health education, not medical advice. Whether any treatment is appropriate for you is a decision made in consultation after assessment.